MoneyWorks4Me

Abbott India informs about unaudited financial results

09 Feb 2022 Evaluate

Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Abbott India has informed that it enclosed a text of Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2021, approved by the Board of Directors at its Meeting held today, Wednesday, February 9, 2022 along with the Limited Review Report issued by SRBC & CO. LLP, Statutory Auditors of the Company. The Meeting of the Board of Directors of the Company commenced at 11.30 am and concluded at 1.50 pm.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..